Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $153K | +4.09K | +3.75% | $37.44 | 113K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$153K | -1.18K | -1.04% | $130.30 | 112K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$149K | -1.15K | -1.02% | $130.30 | 111K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Options Exercise | $333K | +4.07K | +3.68% | $81.81 | 115K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$333K | -2.56K | -2.23% | $130.32 | 112K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$77.8K | -597 | -0.53% | $130.32 | 112K | May 10, 2024 | Direct | |
transaction | EOG | Common Stock | Sale | -$230K | -1.77K | -1.58% | $130.29 | 110K | May 13, 2024 | Direct | |
transaction | EOG | Common Stock | Sale | -$120K | -919 | -0.84% | $130.30 | 109K | May 13, 2024 | Direct | |
holding | EOG | Common Stock | 8K | May 10, 2024 | Family Trust (AD) | ||||||
holding | EOG | Common Stock | 8K | May 10, 2024 | Family Trust (KD) | ||||||
holding | EOG | Common Stock | 8K | May 10, 2024 | Family Trust (PD) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4.09K | -100% | $0.00* | 0 | May 10, 2024 | Common Stock | 4.09K | $37.44 | Direct | F1 |
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4.07K | -49.92% | $0.00 | 4.09K | May 10, 2024 | Common Stock | 4.07K | $81.81 | Direct | F2 |
Id | Content |
---|---|
F1 | The SARs granted became exercisable in increments of 33.3%, 33.3%, and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. |
F2 | The SARs granted become exercisable in increments of 33.3%, 33.3%, and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted become fully exercisable on September 27, 2024. |